Evogene Ltd.
NASDAQ: EVGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ofer Haviv
- Employees
- 117
- Headquarters
- Rehovot, Israel
- IPO year
- 2010
- Market cap
- $3.8M
- Website
- https://www.evogene.com
Loading EVGN…
Loading profile data…Frequently asked questions about EVGN
What does Evogene Ltd. (EVGN) do?
Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep bio...
Where does EVGN trade?
Evogene Ltd. (EVGN) trades on the NASDAQ Global Market.
What sector is EVGN in?
Evogene Ltd. (EVGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Evogene Ltd.?
Ofer Haviv is the chief executive officer of Evogene Ltd. (EVGN).
Where is Evogene Ltd. headquartered?
Evogene Ltd. is headquartered in Israel.
Does EVGN pay a dividend?
Evogene Ltd. (EVGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EVGN go public?
Evogene Ltd. (EVGN) completed its initial public offering in 2010.